Commentary
Classroom Ideology
The Disastrous Domino Effect of Social Promotion
Low student scores on national and state reading tests expose the disturbing reality that a lot of children are being promoted from one grade to the next even though they do not have the knowledge and skills necessary to succeed. Reading is the foundational skill that all children need to ...
Commentary
Direct-To-Consumer Ozempic Sales Are A Win For Patients And Drug Makers
Google Wegovy. Or Zepbound. The search results offer a preview of a direct-to-consumer future for prescription drugs. The brand-name drugs’ homepages generally get top billing. But not far down are ads for telehealth companies promising access to the drugs or others with the same active pharmaceutical ingredient, or API, without ...
Commentary
Dr Currie Myers Interview of Steve Smith
An eye-opening discussion on the real state of public safety in the Golden State
Commentary
Is Era of Biomedical Innovation Wins Against Cancer Over?
For evidence of the astounding progress made by medical science in recent decades, look no further than the Annual Report to the Nation on the Status of Cancer, which was jointly issued by the American Cancer Society, the Centers for Disease Control and Prevention, the North American Association of Central ...
Commentary
A Most Flawed Notion: Medicaid ‘Fix’ Will Worsen 340B Crisis
Congressional Republicans are under pressure to find savings to make the math in their budget reconciliation package add up. Medicaid, which accounts for just under 10% of federal spending, has become an obvious target. But instead of addressing the flawed incentives driving the program’s unsustainability, the Trump administration is pushing ...
California
California’s green new scam could cost you $20,000
California has long fancied itself a beacon of environmental progress, a state willing to lead the charge in combating global warming. But the reality is that this pursuit of a “green” future is coming at a staggering cost to California consumers and businesses, a cost that’s becoming increasingly unsustainable. Read ...
Commentary
Insurers, bureaucrats shouldn’t deprive patients of lifesaving treatments
Imagine being told there’s a drug that might save your life — but your insurance won’t cover it for 18 months. That’s the reality for patients under a new policy from Independence Blue Cross, a Philadelphia-based insurer. The insurer announced earlier this year that it will delay coverage of therapies ...
Commentary
Why Are Republicans Acquiescing To Tax Hikes?
The White House is advancing a policy that would raise drug prices, stifle medical innovation, and hand China a strategic edge in the race for global technological dominance. No, Joe Biden hasn’t somehow returned to office. This time, the ill-advised idea — tariffs on imported medicines — comes from Donald ...
Commentary
Congress Should Not Impose Foreign Price Controls On Innovative Drugs
Simple and neat solutions are alluring but often wrong. A case in point is President Trump’s proposal to adopt a most favored nation (MFN) policy. The MFN sets Medicaid’s price for a drug at the lowest price charged in other developed countries each of which has price controls on drugs. ...
Commentary
Medicaid isn’t a federal entitlement
Sen. Bill Cassidy (R-LA) recently ripped into progressives for opposing Medicaid reform. “Medicaid is meant to be a state-federal partnership,” Cassidy, who has an M.D., wrote on X. “States are supposed to pay for 40% of the cost. Most states are paying for less than 15%. … People should not ...
The Disastrous Domino Effect of Social Promotion
Low student scores on national and state reading tests expose the disturbing reality that a lot of children are being promoted from one grade to the next even though they do not have the knowledge and skills necessary to succeed. Reading is the foundational skill that all children need to ...
Direct-To-Consumer Ozempic Sales Are A Win For Patients And Drug Makers
Google Wegovy. Or Zepbound. The search results offer a preview of a direct-to-consumer future for prescription drugs. The brand-name drugs’ homepages generally get top billing. But not far down are ads for telehealth companies promising access to the drugs or others with the same active pharmaceutical ingredient, or API, without ...
Dr Currie Myers Interview of Steve Smith
An eye-opening discussion on the real state of public safety in the Golden State
Is Era of Biomedical Innovation Wins Against Cancer Over?
For evidence of the astounding progress made by medical science in recent decades, look no further than the Annual Report to the Nation on the Status of Cancer, which was jointly issued by the American Cancer Society, the Centers for Disease Control and Prevention, the North American Association of Central ...
A Most Flawed Notion: Medicaid ‘Fix’ Will Worsen 340B Crisis
Congressional Republicans are under pressure to find savings to make the math in their budget reconciliation package add up. Medicaid, which accounts for just under 10% of federal spending, has become an obvious target. But instead of addressing the flawed incentives driving the program’s unsustainability, the Trump administration is pushing ...
California’s green new scam could cost you $20,000
California has long fancied itself a beacon of environmental progress, a state willing to lead the charge in combating global warming. But the reality is that this pursuit of a “green” future is coming at a staggering cost to California consumers and businesses, a cost that’s becoming increasingly unsustainable. Read ...
Insurers, bureaucrats shouldn’t deprive patients of lifesaving treatments
Imagine being told there’s a drug that might save your life — but your insurance won’t cover it for 18 months. That’s the reality for patients under a new policy from Independence Blue Cross, a Philadelphia-based insurer. The insurer announced earlier this year that it will delay coverage of therapies ...
Why Are Republicans Acquiescing To Tax Hikes?
The White House is advancing a policy that would raise drug prices, stifle medical innovation, and hand China a strategic edge in the race for global technological dominance. No, Joe Biden hasn’t somehow returned to office. This time, the ill-advised idea — tariffs on imported medicines — comes from Donald ...
Congress Should Not Impose Foreign Price Controls On Innovative Drugs
Simple and neat solutions are alluring but often wrong. A case in point is President Trump’s proposal to adopt a most favored nation (MFN) policy. The MFN sets Medicaid’s price for a drug at the lowest price charged in other developed countries each of which has price controls on drugs. ...
Medicaid isn’t a federal entitlement
Sen. Bill Cassidy (R-LA) recently ripped into progressives for opposing Medicaid reform. “Medicaid is meant to be a state-federal partnership,” Cassidy, who has an M.D., wrote on X. “States are supposed to pay for 40% of the cost. Most states are paying for less than 15%. … People should not ...
